Source link : https://newshealth.biz/health-news/fda-approves-first-pcsk9-inhibitor-in-pill-form/
The FDA approved enlicitide (Lipfendra) as the first oral PCSK9 inhibitor for lowering cholesterol. Enlicitide is now approved as an adjunct to diet and exercise to reduce LDL cholesterol in adults with high cholesterol or heterozygous familial hypercholesterolemia (HeFH). Enlicitide comes as a 20-mg tablet taken by mouth once a day, the suggestion being after […]
The post FDA Approves First PCSK9 Inhibitor in Pill Form first appeared on News Health.
—-
Author : News Health
Publish date : 2026-07-16 17:18:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8